Ribose and Sport Performance

December 2, 2016 updated by: Laval University

The Effect of Ribose on Performance and Recovery in Athletes

Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Quebec
      • Québec, Quebec, Canada, G1V0A6
        • Universite Laval

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women
  • Training volume > 7hrs/week
  • VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
  • Otherwise healthy individuals

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
  • Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
  • Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ribose
After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.
Other: Ribose
After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.
Placebo Comparator: Placebo
After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.
Other: Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in time to complete the third of 3 consecutive 3km time trials on bike
Time Frame: baseline and 1 week
baseline and 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance on the 3 consecutive 3km time trials on bike
Time Frame: baseline and 1 week
Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)
baseline and 1 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue perception after each of the 3 consecutive 3km time trials on bike
Time Frame: baseline and 1 week
Post-exercise fatigue perception on visual analog scale (VAS)
baseline and 1 week
Peak Vo2 consumption during each of the 3km time trials on bike
Time Frame: baseline and 1 week
baseline and 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Laval University

Collaborators

Atrium Innovations

Investigators

  • Principal Investigator: Benoît Lamarche, PhD, Institute on nutraceuticals and functional foods

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

November 2, 2012

First Submitted That Met QC Criteria

November 15, 2012

First Posted (Estimate)

November 16, 2012

Study Record Updates

Last Update Posted (Estimate)

December 5, 2016

Last Update Submitted That Met QC Criteria

December 2, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2012-048
  • INAF-2012-048

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports

Clinical Trials on Placebo

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe